1. Restoring Treatment Response in Colorectal Cancer Cells by Targeting MACC1-Dependent ABCB1 Expression in Combination Therapy
   Mathias Dahlmann et al, 2020, Frontiers in Oncology CrossRef
2. Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells
   María Julia Martín et al, 2021, European Journal of Pharmaceutical Sciences CrossRef
3. Involvement of parathyroid hormone-related peptide in the aggressive phenotype of colorectal cancer cells
   María Belén Novoa Díaz et al, 2021, World Journal of Gastroenterology CrossRef
4. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer
   Isaac Micallef et al, 2021, Non-Coding RNA CrossRef
5. Inhibition of CNOT2 Induces Apoptosis via MID1IP1 in Colorectal Cancer Cells by Activating p53
   Ji Hoon Jung et al, 2021, Biomolecules CrossRef
6. Shape-Tunable UV-Printed Solid Drugs for Personalized Medicine
   Bobby Aditya Darmawan et al, 2022, Polymers CrossRef
7. Synthesis of Polyethylene Glycol Diacrylate/Acrylic Acid Nanoparticles as Nanocarriers for the Controlled Delivery of Doxorubicin to Colorectal Cancer Cells
   Yin Yin Myat et al, 2022, Pharmaceutics CrossRef
8. A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
   Maolin Wang et al, 2021, Frontiers in Oncology CrossRef